CFSMX | JVMSX | CFSMX / JVMSX | |
Total Expense Ratio | 0.85 | 1.25 | 68% |
Annual Report Gross Expense Ratio | 0.88 | 1.26 | 70% |
Fund Existence | 10 years | 13 years | - |
Gain YTD | -11.295 | -2.424 | 466% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 978M | 20.6B | 5% |
Annual Yield % from dividends | 0.56 | 0.46 | 122% |
Returns for 1 year | -5.60 | -8.45 | 66% |
Returns for 3 years | -15.70 | 4.66 | -337% |
Returns for 5 years | 15.53 | 50.94 | 30% |
Returns for 10 years | N/A | 27.80 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 78.04 | 0.69 | +0.89% |
SPDR® S&P Biotech ETF | |||
XBAP | 35.08 | 0.15 | +0.44% |
Innovator US Eq Acltd 9 Bfr ETFTM April | |||
MARW | 31.14 | 0.11 | +0.34% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
DFSI | 37.11 | -0.01 | -0.02% |
Dimensional International Sstby Cr 1 ETF | |||
BFIX | 25.14 | -0.08 | -0.30% |
Build Bond Innovation ETF |